S. Roemeling

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S Roemeling, S. Roemeling, Stijn Roemeling
Publication record
58 papers · 2,038 citations · H-index 20

PAPERS

Cone-beam computed tomography assisted percutaneous nephrolithotomy in a hybrid operating room: Evaluation of experience and optimization of patient selection
20230 citationsauthor #5
Recovery after ureterorenoscopy and percutaneous nephrolithotomy
20220 citationsauthor #5
Intraoperative cone beam computed tomography for detecting residual stones in percutaneous nephrolithotomy: a feasibility study
202110 citationsauthor #5
Cone beam computed tomography for detecting residual stones in percutaneous nephrolithotomy, a randomized controlled trial (CAPTURE) protocol
20214 citationsauthor #4
Non-iatrogenic nephro-pleural fistula in a child
20211 citationsauthor #2
V04-07 CONE-BEAM COMPUTED TOMOGRAPHY IN A HYBRID OPERATING ROOM FOR DETECTION OF RESIDUAL STONES DURING PERCUTANEOUS NEPHROLITHOTOMY
20200 citationsauthor #5
End-fire versus side-fire: a randomized controlled study of transrectal ultrasound guided biopsies for prostate cancer detection
20203 citationsauthor #5
Intra-operative cone-beam computed tomography for detecting residual stones in percutaneous nephrolithotomy
20200 citationsauthor #5
[Asymptomatic microscopic haematuria: usually not a problem].
20170 citationsauthor #1
Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)
201034 citationsauthor #5
Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study
2010174 citationsauthor #14
829 STANDARD REPEAT BIOPSIES DURING ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER: PREDICTORS FOR UPGRADING OR UPSTAGING
20090 citationsauthor #2
PROSPECTIVE PROTOCOL BASED ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER: SHORT-TERM RESULTS OF 500 PATIENTS IN THE PRIAS STUDY
20092 citationsauthor #7
Gleason score 7 screen‐detected prostate cancers initially managed expectantly: outcomes in 50 men
200947 citationsauthor #2
Platinum Priority – Reply from Authors re: Peter C. Albertsen. The Treatment Paradigm Shifts Again on Prostate Cancer. Eur Urol 2009;55:9–11
20091 citationsauthor #2
959 PROSPECTIVE PROTOCOL BASED ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER: SHORT-TERM RESULTS OF 500 PATIENTS IN THE PRIAS STUDY
20090 citationsauthor #7
Platinum Priority - Reply from Authors re: Peter C. Albertsen. The Treatment Paradigm Shifts Again on Prostate Cancer.
20090 citationsauthor #2
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly.
2009290 citationsauthor #2
[The need for orchiopexy in the case of congenital undescended testis].
20092 citationsauthor #2
The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
2008156 citationsauthor #3
ANXIETY IN MEN ON ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER
20080 citationsauthor #5
Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
200818 citationsauthor #2
Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.
200853 citationsauthor #2
Words of wisdom. Re: Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.
20089 citationsauthor #1
Can non‐malignant biopsy features identify men at increased risk of biopsy‐detectable prostate cancer at re‐screening after 4 years?
200819 citationsauthor #5
OVERALL VERSUS DISEASE-SPECIFIC SURVIVAL OF SCREEN- DETECTED PROSTATE CANCER PATIENTS WHO WERE INITIALLY MANAGED EXPECTANTLY
20083 citationsauthor #1
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer
200889 citationsauthor #4
The value of an additional hypoechoic lesion‐directed biopsy core for detecting prostate cancer
200846 citationsauthor #3
1027 OUTCOME OF SCREEN-DETECTED PROSTATE CANCER PATIENTS WHO COULD HAVE BEEN CONSIDERED FOR ACTIVE SURVEILLANCE
20074 citationsauthor #1
403 LONG-TERM FOLLOW-UP OF HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL FOCI SUSPICIOUS FOR CARCINOMA ON SEXTANT PROSTATE NEEDLE BIOPSY
20070 citationsauthor #3
Prospective validation of active surveillance in prostate cancer: the PRIAS study.
2007254 citationsauthor #2
1026 NOMOGRAM USE FOR THE PREDICTION OF INDOLENT PROSTATE CANCER IN MEN SELECTED FOR ACTIVE SURVEILLANCE
20071 citationsauthor #1
Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.
200732 citationsauthor #4
Nomogram use for the prediction of indolent prostate cancer
200774 citationsauthor #1
607 OVERALL SURVIVAL IN THE INTERVENTION ARM OF A RANDOMIZED CONTROLLED SCREENING TRIAL FOR PROSTATE CANCER COMPARED TO A CLINICALLY DIAGNOSED COHORT
20071 citationsauthor #2
Screening for prostate cancer at low PSA range: The impact of digital rectal examination on tumor incidence and tumor characteristics
200747 citationsauthor #3
Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.
2007165 citationsauthor #1
1025 VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF INDOLENT DISEASE ON SCREEN DETECTED PROSTATE CANCER CASES INITIALLY TREATED WITH ACTIVE SURVEILLANCE
20071 citationsauthor #3
Feasibility study of adjustment for contamination and non‐compliance in a prostate cancer screening trial
200725 citationsauthor #1
Overdiagnosis and overtreatment of early detected prostate cancer
2007203 citationsauthor #2
Screening for Prostate Cancer: Intermediate Outcome Measures and Active Surveillance
20070 citationsauthor #1
Should we replace the Gleason score with the amount of high-grade prostate cancer?
200754 citationsauthor #2
400 THE VALUE OF AN ADDITIONAL HYPOECHOGENIC LESION-DIRECTED BIOPSY FOR THE DETECTION OF PROSTATE CANCER
20070 citationsauthor #3
Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population.
200637 citationsauthor #1
Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
200631 citationsauthor #1
PSA and the Detection of Prostate Cancer After 2005. Part II: Ways Out of the PSA Dilemma?
20061 citationsauthor #3
Metastatic disease of screen‐detected prostate cancer
20062 citationsauthor #1
Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels
20065 citationsauthor #1
Prostate cancer: risks and benefits of screening
20063 citationsauthor #1
METASTATIC DISEASE RATES AFTER RADICAL PROSTATECTOMY AND RADIOTHERAPY IN SCREEN-DETECTED PROSTATE CANCER
20061 citationsauthor #1
SHOULD WE REPLACE THE GLEASON SCORE WITH THE AMOUNT OF HIGH-GRADE CANCER?
20061 citationsauthor #2
PSA and the Detection of Prostate Cancer After 2005. Part I
200611 citationsauthor #3
Screening for prostate cancer without digital rectal examination and transrectal ultrasound: Results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
200636 citationsauthor #3
1472: Death From Screen-Detected Prostate Cancer; the Demographics at Diagnosis
20060 citationsauthor #1
Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.
200686 citationsauthor #1
PATHWAYS TO THE DIAGNOSIS OF PROSTATE CANCER IN THE CONTROL ARM OF A LARGE RANDOMISED SCREENING TRIAL
20060 citationsauthor #2
304Influence of deferred treatment with curative intent on progression free survival rates in prostate cancer
20051 citationsauthor #1
Epidural Metastatic Abscess from an Infected Femoral Head Prosthesis Presenting with Hemiplegia
20050 citationsauthor #1

TIMELINE

2005 1 citations

2006 214 citations

2007 861 citations

2008 393 citations

2009 342 citations

2010 208 citations

2017 0 citations

2020 3 citations

2021 15 citations

2022 0 citations

2023 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT